Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Summary
This is a multi-center, randomized, double-blind, double-dummy, parallel-controled, phase III trial, aiming to evaluate the effectiveness and safety of long-term continuous administration of Vicagrel capsules in ACS patients undergoing PCI.
Official title: Efficacy and Safety of Vicagrel in Patients With With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI): a Multi-center, Randomized, Double-blind, Double-dummy , Parallel-controlled, Phase III Trial
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2024-09-06
Completion Date
2026-12-30
Last Updated
2024-10-01
Healthy Volunteers
No
Interventions
Vicagrel
Vicagrel loading followed by Maintenance dose
Clopidogrel
Clopidogrel loading followed by Maintenance dose
Locations (1)
General Hospital of Northern Theater Command of Chinese PLA
Shenyang, Liaoning, China